Summary & Overview
Transurethral Procedures with CC: Inpatient Reimbursement Overview
DRG 669 addresses inpatient transurethral procedures with a Complication or Comorbidity and encompasses endoscopic interventions for lower urinary tract conditions that increase resource use. It matters for inpatient reimbursement because assignment to this Diagnosis-Related Group—based on procedure codes and documented secondary diagnoses—affects the Medicare payment level for the admission.
DRG 669 Overview
DRG 669 covers inpatient admissions for transurethral procedures for the male or female lower urinary tract when a Complication or Comorbidity is present. Typical cases include transurethral resection, ablation, or other endoscopic interventions for obstruction, bleeding, or benign and malignant lesions where an additional diagnosis increases resource use. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity raises the relative weight and Medicare inpatient prospective payment compared with cases without such secondary diagnoses. Accurate documentation and coding of the qualifying procedures and accompanying Complication or Comorbidity determine assignment to this Diagnosis-Related Group and the resulting hospital reimbursement.